Treating Inflammatory Arthritis to Target Protects Blood Vessels from Atherosclerosis
Two-year study shows aggressive treatment of axial spondyloarthritis reduces arterial plaque buildup by 73% when low disease activity is achieved.
Summary
Researchers followed 90 people with axial spondyloarthritis (a type of inflammatory arthritis affecting the spine) for two years using aggressive treatment targeting low disease activity. Those who achieved and maintained low inflammation had 73% less progression of arterial plaque buildup compared to those with ongoing inflammation. The study measured carotid artery thickness and plaque formation using ultrasound. This suggests that controlling chronic inflammation doesn't just reduce joint symptoms—it actively protects blood vessels from atherosclerosis, potentially reducing heart attack and stroke risk. The findings highlight how systemic inflammation accelerates cardiovascular aging.
Detailed Summary
Chronic inflammation accelerates cardiovascular aging, but this study demonstrates that aggressively treating inflammatory conditions can protect blood vessels. Researchers tracked how controlling axial spondyloarthritis—an inflammatory arthritis affecting the spine—impacts arterial health over time.
The two-year study followed 90 patients receiving intensive treatment aimed at achieving low disease activity scores. Researchers used high-resolution ultrasound to measure carotid artery thickness and plaque formation, plus arterial stiffness measurements. Patients were divided based on whether they achieved sustained low inflammation levels.
Results were striking: 74% of patients achieved low disease activity at one year, with 50% maintaining it throughout the study. Those reaching low inflammation had 73% reduced odds of carotid plaque progression. Patients maintaining sustained low activity showed significant reductions in total plaque area over 24 months. However, arterial stiffness measurements showed no significant differences between groups.
For longevity optimization, this research reinforces that inflammation control extends beyond symptom management—it actively slows cardiovascular aging. The study suggests that aggressive anti-inflammatory treatment can reverse or slow atherosclerotic progression, potentially reducing heart attack and stroke risk. This has implications for anyone with chronic inflammatory conditions.
Limitations include the specific patient population (mostly young Asian males), relatively short follow-up period, and focus on one inflammatory condition. The lack of arterial stiffness improvements suggests plaque reduction may precede functional vascular changes, requiring longer observation periods to detect.
Key Findings
- Achieving low disease activity reduced carotid plaque progression by 73% over two years
- Sustained inflammation control significantly decreased total arterial plaque area
- 74% of patients achieved target low inflammation levels with aggressive treatment
- Arterial stiffness showed no improvement despite reduced plaque formation
Methodology
Prospective 2-year treat-to-target study of 90 axial spondyloarthritis patients (mean age 39, 81% male). High-resolution ultrasound measured carotid intima-media thickness and plaque progression. Primary endpoint compared vascular changes between patients achieving versus not achieving low disease activity.
Study Limitations
Study focused on specific inflammatory arthritis in predominantly young Asian males, limiting generalizability. Two-year follow-up may be insufficient to detect arterial stiffness changes. Results may not apply to other inflammatory conditions or populations.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.